Healthcare provider profile · identity verified

Robert William Sedlacek, M.D.

Family Practice · WAUPACA, WI · NPI 1003072687

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	364	93
Lisinopril	Lisinopril	216	54
Trazodone Hcl	Trazodone Hcl	213	30
Losartan Potassium	Losartan Potassium	164	43
Gabapentin	Gabapentin	161	36
Levothyroxine Sodium	Levothyroxine Sodium	157	36
Metformin Hcl	Metformin Hcl	156	36
Amlodipine Besylate	Amlodipine Besylate	139	41
Omeprazole	Omeprazole	137	40
Rosuvastatin Calcium	Rosuvastatin Calcium	137	42
Eliquis	Apixaban	113	28
Simvastatin	Simvastatin	110	31
Metoprolol Succinate	Metoprolol Succinate	107	36
Tamsulosin Hcl	Tamsulosin Hcl	106	26
Furosemide	Furosemide	102	33
Hydrochlorothiazide	Hydrochlorothiazide	101	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	99	16
Sertraline Hcl	Sertraline Hcl	88	18
Finasteride	Finasteride	85	15
Lorazepam	Lorazepam	85	12
Metoprolol Tartrate	Metoprolol Tartrate	81	22
Trulicity	Dulaglutide	76	11
Pantoprazole Sodium	Pantoprazole Sodium	74	22
Tramadol Hcl	Tramadol Hcl	73	suppressed
Jardiance	Empagliflozin	70	20
Donepezil Hcl	Donepezil Hcl	69	14
Escitalopram Oxalate	Escitalopram Oxalate	68	11
Duloxetine Hcl	Duloxetine Hcl	67	11
Potassium Chloride	Potassium Chloride	65	15
Metformin Hcl Er	Metformin Hcl	62	18
Memantine Hcl	Memantine Hcl	57	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	56	26
Diclofenac Sodium	Diclofenac Sodium	55	14
Famotidine	Famotidine	54	11
Chlorthalidone	Chlorthalidone	53	16
Fluticasone Propionate	Fluticasone Propionate	49	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	48	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	42	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	suppressed
Allopurinol	Allopurinol	41	14
Meloxicam	Meloxicam	41	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	17
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Ibuprofen	Ibuprofen	39	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Rexulti	Brexpiprazole	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	34	11
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Baclofen	Baclofen	33	suppressed
Clonazepam	Clonazepam	33	suppressed
Ozempic	Semaglutide	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	13
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Carvedilol	Carvedilol	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Diazepam	Diazepam	26	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Doxepin Hcl	Doxepin Hcl	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	23	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Estradiol	Estradiol	22	suppressed
Nitroglycerin	Nitroglycerin	22	16
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Valsartan	Valsartan	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Divalproex Sodium Er	Divalproex Sodium	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Invokana	Canagliflozin	20	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Glydo	Lidocaine Hcl	19	suppressed
Lovastatin	Lovastatin	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Acyclovir	Acyclovir	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	16	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Atenolol	Atenolol	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Cefdinir	Cefdinir	13	11
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	12	suppressed
Galantamine Hbr	Galantamine Hbr	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Glipizide	Glipizide	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Trospium Chloride	Trospium Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error